Product logins

Find logins to all Clarivate products below.


Therapeutic Botulinum Toxin | Medtech 360 | Market Analysis | Global | 2019

The global therapeutic BTX market will grow strongly through 2027, with newly approved indications, the need for repeat BTX treatments, and a largely favorable reimbursement environment driving significant procedure volume and unit sales expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, France, Germany, Italy, Spain, the UK, Japan and Australia across a 10-year period.

Related Medtech Insights Reports

Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will grow modestly, driven by increasing complex CAD cases and the adoption of surgical technologies. Favorable clinical evidence, particularly in favor of CABG over PCI,…
Report
Therapeutic Botulinum Toxin – Market Insights – Global
Global therapeutic BTX procedure volumes—and thus product sales and revenues—will be supported by the need for existing patients to return for maintenance procedures, as well as rising demand…
Report
Biosurgical Agents | Medtech 360 | Market Insights | US | 2024
The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…
Report
Diagnostic Imaging Systems – Market Insights – Japan
The diagnostic imaging system market in Japan will see slow growth through 2032. Manufacturers in this space are actively introducing technologically advanced products equipped with digital and AI…
Report
Therapeutic Botulinum Toxin | Market Insights | Global | 2024
Global therapeutic BTX procedure volumes—and thus product sales and revenues—will be supported by the need for existing patients to return for maintenance procedures, as well as rising…